These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26498680)

  • 21. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
    Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
    Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
    Jia L; Xu H; Zhao Y; Jiang L; Yu J; Zhang J
    Cancer Invest; 2008 Dec; 26(10):977-83. PubMed ID: 19093255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of (131)I-labeled anti-CD147 monoclonal antibody in VX2 carcinoma-induced liver tumors.
    Niu H; Wang R; Cheng J; Gao S; Liu B
    Oncol Rep; 2013 Jul; 30(1):246-52. PubMed ID: 23612800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of silencing chloride intracellular channel 1 gene expression on the proliferation and invasion of mouse hepatocellular carcinoma cell lines].
    Li RK; Tang JW; Zhang J; Wang SQ; Wang M; Wang B; Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):131-5. PubMed ID: 20196953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle.
    Tian Y; Huang C; Zhang H; Ni Q; Han S; Wang D; Han Z; Li X
    Int J Oncol; 2013 Dec; 43(6):2082-90. PubMed ID: 24141559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
    Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
    Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. βig-h3 regulates store-operated Ca2+ entry and promotes the invasion of human hepatocellular carcinoma cells.
    Guo YS; Tang J; Chen B; Huang W; Li Y; Cui HY; Zhang X; Wang SJ; Chen ZN; Jiang JL
    Cell Biol Int; 2011 Aug; 35(8):811-7. PubMed ID: 21395558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma.
    Li JH; Huang W; Lin P; Wu B; Fu ZG; Shen HM; Jing L; Liu ZY; Zhou Y; Meng Y; Xu BQ; Chen ZN; Jiang JL
    Sci Rep; 2016 Nov; 6():35210. PubMed ID: 27869218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma.
    Chakraborty S; Lakshmanan M; Swa HL; Chen J; Zhang X; Ong YS; Loo LS; Akıncılar SC; Gunaratne J; Tergaonkar V; Hui KM; Hong W
    Nat Commun; 2015 Jan; 6():6184. PubMed ID: 25630468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.